Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2024/08/072382
CTRI/2024/08/072382Not yet recruitingNot Applicable

Prolactin levels in Obese type 2 Diabetes mellitus patients and its association with Carotid intima media thickness.

Not provided1 site in 1 country224 target enrollmentStarted: August 23, 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
224
Locations
1
Primary Endpoint
To determine the levels of Prolactin in Obese Type 2 Diabetes mellitus patients.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The study includes recruiting Obese patients with Type 2 Diabetes mellitus presenting to OPD and IPD of Internal medicine department, and those meeting the inclusion criteria will be enrolled in the study. Detailed history will be taken and Anthropometry will be done. Once the patient fits the inclusion criteria, they will be explained about the study and written informed consent will be taken. USG Carotid doppler will be taken to measure Carotid intima media thickness. Serum Prolactin levels will be measured. The results will be compared with healthy volunteers who are non-obese and non-diabetic. And thus the association between Serum Prolactin levels and Carotid intimal and medial thickness with Obese Type 2 Diabetes mellitus will be determined.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patients more than 18 years of age.
  • •Patients with Type 2 Diabetes mellitus and Obesity.

Exclusion Criteria

  • •Pregnant females.
  • •Patients less than 18 years of age.

Outcomes

Primary Outcomes

To determine the levels of Prolactin in Obese Type 2 Diabetes mellitus patients.

Time Frame: Prolactin levels will be assessed during the first visit of the patient.

Secondary Outcomes

  • To determine the association between Prolactin levels & carotid intimal medial thickness in Obese patients with Type 2 Diabetes mellitus.(Prolactin levels & carotid intima media thickness shall be measured on the first visit. Each patient prolactin level will be correlated with their carotid intima & medial thickness on the first visit itself. No follow up is needed further in this study.)

Investigators

Sponsor
Not provided
Responsible Party
Principal Investigator
Principal Investigator

Arun Kumar

AIIMS Bathinda

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 3
Diabic Care Juice in Type 2 Diabetic Patients
CTRI/2024/02/063389Mr Shrawan Daga36
Recruiting
Phase 4
Interventional, Single arm, open-label study to evaluate the efficacy and safety of Imeglimin using Continuous Glucose Monitoring (CGM) in Type 2 Diabetes Mellitus (T2DM) patientsDiabetes
CTRI/2025/02/079966Dr Unnikrishnan Ambika Gopalakrishnan30
Not yet recruiting
Not Applicable
Study of Prediabetes in Overweight People Living in Kanpur City
CTRI/2025/09/094126NO250
Not yet recruiting
Phase 2
Clinical study of nutritional formulations in prediabetes and type 2 diabetes mellitus.
CTRI/2024/07/070146Life Synergy150
Not yet recruiting
Not Applicable
Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and AdultsDiabetesObesity
NCT07388537National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1,000